We found that RPL4P4 was significantly overexpressed in gliomas and that increased RPL4P4 expression correlated significantly with poor outcomes, tumor grade, age, IDH mutation status, and chromosome 1p/19q codeletion status. The gene discussed is IDH1; the disease is central nervous system cancer.